Molecular diagnosis of T cell-mediated rejection in human kidney transplant biopsies

American Journal of Transplantation

Volumn 13, Issue 3, 2013, Pages 645-655

  Reeve, J ^a,b   Sellares J ^a,c   Mengel, M ^a,b   Sis, B ^b   Skene, A ^a   Hidalgo, L ^a,b   De Freitas, D G ^d   Famulski, K S ^a,b   Halloran, P F ^a,b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^d MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Biopsy; classifier; kidney transplant; microarray; rejection

Indexed keywords

ACCURACY; ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; GRAFT REJECTION; HISTOLOGY; HUMAN; HUMAN TISSUE; KIDNEY GRAFT; MALE; MICROARRAY ANALYSIS; MOLECULAR DIAGNOSIS; PREDICTIVE VALUE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; T CELL MEDIATED REJECTION; T LYMPHOCYTE; TISSUE INJURY; VASCULITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; FEMALE; GENE EXPRESSION PROFILING; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; INFLAMMATION; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; PROSPECTIVE STUDIES; T-LYMPHOCYTES; YOUNG ADULT;

EID: 84874439800     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12079     Document Type: Article

References (39)

1. Halloran PF,. T cell mediated rejection of kidney transplants: A personal viewpoint. Am J Transplant 2010; 10: 1126-1134.
2. Vincenti F, Charpentier B, Vanrenterghem Y, et al. A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study). Am J Transplant 2010; 10: 535-546.
3. Mengel M, Sis B, Halloran PF,. SWOT analysis of Banff: Strengths, weaknesses, opportunities, and threats of the international Banff consensus process and classification system for renal allograft pathology. Am J Transplant 2007; 7: 2221-2226.
4. Racusen L, Kashgarian M,. Ischemic and toxic acute tubular injury and other ischemic renal injury. In:, Jennette JC, Olson JL, Schwartz MM, Silva FG, Eds. Heptinstall's Pathology of the Kidney. Sixth ed. Philadelphia: Lippincott Williams and Wilkins; 2007. p. 1139-1198.
5. Racusen LC, Solez K,. Nephrotoxic tubular and interstitial lesions: Morphology and classification. Toxicol Pathol 1986; 14: 45-57.
6. Mengel M, Chang J, Kayser D, et al. The molecular phenotype of six-week protocol biopsies from human renal allografts: Reflections of prior injury but not future course. Am J Transplant 2011; 11: 708-718.
7. Reeve J, Einecke G, Mengel M, et al. Diagnosing rejection in renal transplants: A comparison of molecular-and histopathology-based approaches. Am J Transplant 2009; 9: 1802-10.
8. Mengel M, Sis B, Haas M, et al. 2011 Meeting report: New concepts in antibody-mediated rejection. Am J Transplant 2012; 12: 563-570.
9. Furness PN, Taub N, Assmann KJ, et al. International variation in histologic grading is large, and persistent feedback does not improve reproducibility. Am J Surg Pathol 2003; 27: 805-810.
10. Furness PN, Taub N,. International variation in the interpretation of renal transplant biopsies: Report of the CERTPAP Project. Kidney Int 2001; 60: 1998-2012.
11. Cardoso F, Van't VL, Rutgers E, Loi S, Mook S, Piccart-Gebhart MJ,. Clinical application of the 70-gene profile: The MINDACT trial. J Clin Oncol 2008; 26: 729-735.
12. Yang M, Rajan S, Issa AM,. Cost effectiveness of gene expression profiling for early stage breast cancer: a decision-analytic model. Cancer 2012; 118: 5163-5170.
13. Prat A, Parker JS, Fan C, et al. Concordance among gene expression-based predictors for ER-positive breast cancer treated with adjuvant tamoxifen. Ann Oncol 2012; 23: 2866-2873.
14. Hartmann S, Gerber B, Elling D, Heintze K, Reimer T,. The 70-gene signature as prognostic factor for elderly women with hormone receptor-positive, HER2-negative breast cancer. Breast Care 2012; 7: 19-24.
15. Strehlau J, Pavlakis M, Lipman M, et al. Quantitative detection of immune activation transcripts as a diagnostic tool in kidney transplantation. Proc Natl Acad Sci USA 1997; 94: 695-700.
16. Suthanthiran M., Clinical application of molecular biology: a study of allograft rejection with polymerase chain reaction. Am J Med Sci 1997; 313: 264-267.
17. Sarwal M, Chua MS, Kambham N, et al. Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N Engl J Med 2003; 349: 125-138.
18. Flechner SM, Kurian SM, Head SR, et al. Kidney transplant rejection and tissue injury by gene profiling of biopsies and peripheral blood lymphocytes. Am J Transplant 2004; 4: 1475-1489.
19. Saint-Mezard P, Berthier CC, Zhang H, et al. Analysis of independent microarray datasets of renal biopsies identifies a robust transcript signature of acute allograft rejection. Transplant Inter 2009; 22: 293-302.
20. Sis B, Jhangri G, Bunnag S, Allanach K, Kaplan B, Halloran PF,. Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining. Am J Transplant 2009; 9: 2312-2323.
21. Einecke G, Sis B, Reeve J, et al. Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. Am J Transplant 2009; 9: 2520-2531.
22. Gaston RS, Cecka JM, Kasiske BL, et al. Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure. Transplant 2010; 90: 68-74.
23. Mueller TF, Einecke G, Reeve J, et al. Microarray analysis of rejection in human kidney transplants using pathogenesis-based transcript sets. Am J Transplant 2007; 7: 2712-2722.
24. Sis B, Mengel M, Haas M, et al. Banff '09 Meeting Report: Antibody Mediated Graft Deterioration and Implementation of Banff Working Groups. Am J Transplant 2010; 10: 464-471.
25. Molinaro AM, Simon R, Pfeiffer RM,. Prediction error estimation: a comparison of resampling methods. Bioinformatics 2012; 21: 3301-3307.
26. Bertini I, Cacciatore S, Jensen BV, et al. Metabolomic NMR fingerprinting to identify and predict survival of patients with metastatic colorectal cancer. Cancer Res 2012; 72: 356-364.
27. Sellares J, De Freitas D, Mengel M, et al. Understanding the causes of kidney transplant failure: The dominant role of antibody-mediated rejection and non-adherence. Am J Transplant 2012; 12: 388-399.
28. Sis B, Jhangri GS, Riopel J, et al. A new diagnostic algorithm for antibody-mediated microcirculation inflammation in kidney transplants. Am J Transplant 2012; 12: 1168-1179.
29. de Freitas DG, Sellares J, Mengel M, et al. The nature of biopsies with "borderline rejection" and prospects for eliminating this category. Am J Transplant 2012; 12: 191-201.
30. Famulski KS, Einecke G, Sis B, et al. Defining the canonical form of T-cell-mediated rejection in human kidney transplants. Am J Transplant 2010; 10: 810-820.
31. Limmathurotsakul D, Turner EL, Wuthiekanun V, Thaipadungpanit J, Suputtamongkol Y, Chierakul W, et al. Fool's Gold. Why imperfect reference tests are undermining the evaluation of novel diagnostics: A reevaluation of 5 diagnostic tests for leptospirosis. Clin Infect Dis 2012; 55: 322-331.
32. Rutjes AW, Reitsma JB, Coomarasamy A, Khan KS, Bossuyt PM,. Evaluation of diagnostic tests when there is no gold standard. A review of methods. Health Technol Assess 2007; 11: iii, ix-51.
33. McAdam AJ,. Discrepant analysis: how can we test a test? J Clin Microbiol 2000; 38: 2027-2029.
34. Olsen S, Burdick JF, Keown PA, Wallace AC, Racusen LC, Solez K,. Primary acute renal failure ("acute tubular necrosis") in the transplanted kidney: morphology and pathogenesis. Medicine 1989; 68: 173-187.
35. Sellares J, Reeve J, Mengel M, Famulski K, Hidalgo L, Halloran PF,. Predictors of response to treatment in biopsy-diagnosed T cell-mediated rejection. Am J Transplant 12 [ s3 ], 322. 2012. Ref Type: Abstract
36. Einecke G, Reeve J, Sis B, et al. A molecular classifier for predicting future graft loss in late kidney transplant biopsies. J Clin Invest 2010; 120: 1862-1872.
37. Famulski KS, de Freitas DG, Kreepala C, et al. Molecular phenotypes of acute kidney injury in human kidney transplants. JASN 2012; 23: 948-958.
38. Mengel M, Reeve J, Bunnag S, et al. Molecular correlates of scarring in kidney transplants: the emergence of mast cell transcripts. Am J Transplant 2009; 9: 169-178.
39. Einecke G, Reeve J, Mengel M, et al. Expression of B cell and immunoglobulin transcripts is a feature of inflammation in late allografts. Am J Transplant 2008; 8: 1434-1443.